Literature DB >> 2918524

The use of low density lipoprotein receptor activity of lymphocytes to determine the prevalence of familial hypercholesterolaemia in a rural South African community.

K Steyn1, M J Weight, B R Dando, K J Christopher, J E Rossouw.   

Abstract

The diagnosis of heterozygous familial hypercholesterolaemia in three rural South African communities in which hypercholesterolaemia is very prevalent could be confirmed by the measurement of low density lipoprotein (LDL) receptor activity in circulating lymphocytes. A nominal cut off point could be proposed which separated the LDL receptor activity of 24 clinically diagnosed heterozygous FH patients and 31 healthy people. LDL receptor activity was measured as total degradation of 125I-LDL and expressed as ng LDL/mg cell protein/6 hours. The cut off point was set at 970 ng/mg protein/6 hours. This proposed cut off point was tested by assaying the LDL receptor of three homozygous FH patients and seven of their obligate heterozygous FH first degree relatives. The three homozygous FH patients showed no receptor activity and the activity of the seven obligate heterozygous first degree relatives fell below the proposed cut off point. To determine the prevalence of FH in the study population, all persons aged 15 to 24 years whose total cholesterol levels fell above the 80th centile for their age and sex, as well as their families, were approached (n = 114). The LDL receptor activity in lymphocytes of 77 of these persons aged 15 to 24 years was determined after applying the exclusion criteria. Ten of the 77 participants had LDL receptor activity below 970 ng LDL/mg protein/6 hours and were therefore diagnosed as being heterozygous FH patients. The calculation of the prevalence (corrected for exclusions) revealed that one in 71 of the 15 to 24 year old permanent residents in the predominantly Afrikaans speaking community suffered from heterozygous FH. This is higher than any FH prevalence previously reported for any group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2918524      PMCID: PMC1015533          DOI: 10.1136/jmg.26.1.32

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

1.  Prevalence of familial hypercholesterolaemia in three rural South African communities.

Authors:  P L Jooste; A J Benadé; J E Rossouw
Journal:  S Afr Med J       Date:  1986-04-26

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Hypercholesterolaemia in the coloured population of the Cape Peninsula (CRISIC study).

Authors:  K Steyn; A J Benadé; M L Langenhoven; G Joubert; J E Rossouw
Journal:  S Afr Med J       Date:  1987-04-18

4.  Association between familial hypercholesterolaemia and church affiliation. Is this the result of sociocultural isolation of migrant farmers in 19th-century South Africa?

Authors:  M Torrington; J L Botha; G J Pilcher; S G Baker
Journal:  S Afr Med J       Date:  1984-05-12

5.  Coronary risk factor screening in three rural communities. The CORIS baseline study.

Authors:  J E Rossouw; J P Du Plessis; A J Benadé; P C Jordaan; J P Kotzé; P L Jooste; J J Ferreira
Journal:  S Afr Med J       Date:  1983-09-17

6.  Low density lipoprotein receptor mutations in South African homozygous familial hypercholesterolemic patients.

Authors:  D R van der Westhuyzen; G A Coetzee; I P Demasius; E H Harley; W Gevers; S G Baker; H C Seftel
Journal:  Arteriosclerosis       Date:  1984 May-Jun

7.  High ischaemic heart disease mortality among young Afrikaners.

Authors:  J P Pretorius
Journal:  S Afr Med J       Date:  1983-09-17

8.  Haplotype associations of three DNA polymorphisms at the human low density lipoprotein receptor gene locus in familial hypercholesterolaemia.

Authors:  M J Kotze; E Langenhoven; A E Retief; K Steyn; M P Marais; J J Grobbelaar; C J Oosthuizen; H F Weich; A J Benadé
Journal:  J Med Genet       Date:  1987-12       Impact factor: 6.318

9.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia.

Authors:  T Langer; W Strober; R I Levy
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

Review 10.  The metabolic basis of familial hypercholesterolemia.

Authors:  N B Myant
Journal:  Klin Wochenschr       Date:  1983-04-15
View more
  3 in total

1.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

2.  South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.

Authors:  J C Defesche; D E van Diermen; P J Lansberg; R J Lamping; P W Reymer; M R Hayden; J J Kastelein
Journal:  Hum Genet       Date:  1993-12       Impact factor: 4.132

3.  LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.

Authors:  Faisal A Al-Allaf; Charles Coutelle; Simon N Waddington; Anna L David; Richard Harbottle; Michael Themis
Journal:  Int Arch Med       Date:  2010-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.